Total returns on $1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | RTW Biotech Opportunities Ltd (Ordinary Share) | +26.67% |
NAV | RTW Biotech Opportunities Ltd (Ordinary Share) | +26.42% |
Morningstar's Benchmark | Russell 2000 Biotech Growth [50.00%]; Nasdaq Biotechnology Index [50.00%] | -- |
Key statistics
As of last trade RTW Biotech Opportunities Ltd (RTW:LSE) traded at 1.55, -10.40% below its 52-week high of 1.73, set on Jul 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 335.71m |
---|---|
Market cap | 510.28m USD |
Total assets | 674.78m USD |
Total expense ratio | 1.97% |
High | 1.55 |
Low | 1.54 |
Previous close | 1.53 |
Average volume | 128.38k |
---|---|
YTD Change | +10.52% |
Beta | 0.6457 |
Diluted NAV (est) | 2.01 |
Diluted NAV (last pub) | 2.01 |
Premium/Discount | -24.48% |
Net Gearing | 0.00% |
Data delayed at least 15 minutes, as of Oct 08 2024 15:05 BST.
More ▼